Skip to Main Content

Advertisement

Skip Nav Destination

Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models

Blood (2023) 142 (12): 1071–1081.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement